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Abstract
Rapid progress in next generation sequencing and allied computational tools have aided in
identification of single nucleotide variants in genomes of several organisms. In the present
study, we have investigated single nucleotide polymorphism (SNP) in ten multi-antibiotic
resistant Pseudomonas aeruginosa clinical isolates. All the draft genomes were submitted
to Rapid Annotations using Subsystems Technology (RAST) web server and the predicted
protein sequences were used for comparison. Non-synonymous single nucleotide polymor-
phism (nsSNP) found in the clinical isolates compared to the reference genome (PAO1),
and the comparison of nsSNPs between antibiotic resistant and susceptible clinical isolates
revealed insights into the genome variation. These nsSNPs identified in the multi-drug resis-
tant clinical isolates were found to be altering a single amino acid in several antibiotic resis-
tant genes. We found mutations in genes encoding efflux pump systems, cell wall, DNA
replication and genes involved in repair mechanism. In addition, nucleotide deletions in the
genome and mutations leading to generation of stop codons were also observed in the anti-
biotic resistant clinical isolates. Next generation sequencing is a powerful tool to compare
the whole genomes and analyse the single base pair variations found within the antibiotic
resistant genes. We identified specific mutations within antibiotic resistant genes compared
to the susceptible strain of the same bacterial species and these findings may provide
insights to understand the role of single nucleotide variants in antibiotic resistance.
Background
Pseudomonas aeruginosa is a major opportunistic pathogen causing acute and chronic infec-
tions in human community. It is a fascinating, ubiquitous, gram-negative bacterium that can
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thrive at low densities within the range of 4˚C to 42˚C and involves in a range of interactions
with eukaryotic hosts [1, 2]. The infection leads to most serious manifestations such as bacter-
emia, pneumonia, urinary tract infections and wound infections [3]. P. aeruginosa is intrinsi-
cally resistant to many antibiotics and the challenge is selection of the most appropriate
antibiotic as the organism can develop resistance during treatment [4, 5].
The infection caused by multi-drug resistant (MDR) P. aeruginosa often leads to morbidity,
mortality, chronic care and an increase towards the overall cost of treating the infection [6, 7].
Mutational changes found within the resistant genes on plasmids or mutations that alter the
function of genes encoded by chromosomes may collectively contribute to the antibiotic resis-
tant mechanisms [8]. The antibiotic resistant mechanisms include the acquisition of extended
spectrum β-lactamases, carbapenemases, aminoglycoside-modifying enzymes and 16S ribo-
somal ribonucleic acid (rRNA) methylases. Mutational changes causing the up regulation of
multidrug efflux pumps, depression of ampC, modification of antimicrobial targets and
changes in the outer membrane permeability barrier have also been reported [8].
Epidemiological typing of P. aeruginosa requires the identification of stable distinguishing
characteristics. Current molecular epidemiological typing techniques in practice such as vari-
able-number tandem repeat (VNTR) and pulsed-field gel electrophoresis (PFGE) have helped
to reveal the outbreaks of P. aeruginosa in hospital settings [9, 10]. However, limited resolu-
tion, cost and complex workflow of these systems make the typing in reference laboratories be
performed in batch mode that affects the real time sequencing efforts. In addition, the tradi-
tional typing methods lacks in providing insights into the evolutionary significance of patho-
gens [11]. Multilocus sequence typing (MLST) to identify specific genes in clinical isolates has
also been reported to be an effective genotyping method [12].
Application of next-generation sequencing (NGS) technology for whole genome, whole pro-
teome and whole transcriptome sequencing is becoming popular. NGS is quick and high
throughput technique that follows a single unified workflow. Using this technique, it is possible
to identify the single-base-pair mutations within same bacterial species that can replace the tra-
ditional molecular typing methods for bacterial pathogens [13]. This approach provides greater
sequence resolution than traditional methods by delivering a definitive catalog of genetic poly-
morphisms, particularly single-nucleotide polymorphisms (SNPs). WGS also associates epide-
miology to genome evolution, genome structure, pathogen biology and gene content; which
provides insights to biological markers, such as antibiotic resistance and virulence factors [14].
Identification of SNPs in bacterial genomes play a key role to determine the relationship
between antibiotic resistant clinical isolates and tracing their evolutionary counterpart [15,
16]. Several studies have reported the genetic variants in cystic fibrosis disease conditions
where the pathogen has emerged because of mutation and long-term colonization [17, 18]. In
addition, genome sequencing facilitates high throughput screening for specific mutations
within antibiotic resistant genes compared to the susceptible and/or reference strain of the
same bacterial species. Thus, in the present study, we examined single nucleotide variations
within the antibiotic resistant and susceptible P. aeruginosa clinical isolates collected from
patients admitted at the University Malaya Medical Centre, Kuala Lumpur, Malaysia. These
nsSNPs found within the antibiotic resistant isolates could potentially alter the amino acid
sequence and may affect the stability and/or the function of the resulting protein expression.
Materials and methods
Bacterial strains and culture condition
P. aeruginosa isolates were collected from different hospital wards (Table 1) at the University
Malaya Medical Centre, Kuala Lumpur, Malaysia over a period of 1 year from April 2009 to
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March 2010. The clinical strains were isolated from urine, wound, blood and indwelling medi-
cal devices. Isolates were frozen with Luria Bertani (LB) broth containing 30% V/V glycerol
and stored at -80˚C until used. The protocol for this study was approved by the Medical Ethics
Committee, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
Antimicrobial susceptibility testing
The antimicrobial susceptibility of isolates was tested using the disc diffusion method (E-
test1) against following nine different antibiotics; piperacillin/tazobactam (PPT), ceftazidime
(CAZ), aztreonam (AZT), amikacin (AK), gentamicin (GN), ciprofloxacin (CIP), imipenem
(IMP), meropenem (MPM) and colistin (CL). The reference strain P. aeruginosa ATCC #
27853 was used to validate the technique. The calibrated carrier strip and the intersection of
the strip to the edge of the inhibitory zone indicates the minimum inhibitory concentration
(MIC) [19]. The clinical isolates were chosen for whole genome sequencing based on the anti-
microbial susceptibility levels screened against different antibiotics.
High-throughput whole genome sequencing
Genomic DNA was isolated from P. aeruginosa clinical isolates using the DNeasy DNA extrac-
tion kit (Qiagen, USA) according to the manufacturer’s instructions. The samples were then
quantified using Qubit. All genomic DNA were fragmented using Covaris S2 at the tempera-
ture of 5.5 to 6˚C for 40 seconds. The fragmented DNA was end repaired, added with dA base
and ligated with Illumina indexed adapters. Size selections of the samples were performed
using Invitrogen 2% agarose E-gels. The selected DNA fragments with adapter molecules on
both ends underwent 10 cycles of PCR amplification and was sequenced using whole genome
shotgun Illumina Hiseq 2000 flow cell V3 with paired-end libraries (~200 base-pair insert
size).
Read pre-processing
Adapter sequences and low quality reads were removed with quality score filter of 30 using
PRINSEQ version 0.20.3 [20]. The following types of reads were removed: reads having ‘N’ in
more than 10% of the total bases of that read, reads with Phred quality score less than 20 and
reads shorter than 50 bp.
Table 1. Selected P. aeruginosa clinical isolates included in the study from University Malaya Medical
Centre, Kuala Lumpur, Malaysia over a period of 1 year from April 2009 to March 2010.
Isolate Ward Specimen
PAS1 Surgery Wound
PAS2 Orthopedic Wound
PAS3 Surgery Urine
PAS4 Surgery Urine
PAS5 Surgery Wound
PAS6 Medical Urine
PAS7 Surgery Urine
PAS8 Pediatric Blood
PAS9 Pediatric Wound
PAS10 Medical Blood
https://doi.org/10.1371/journal.pone.0182524.t001
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Genome assembly
The sequenced reads were assembled using SPAdes Assembler version 3.8.1 [21]. Assembler
was run using iterative kmer lengths ranging from 27 to 77. The assemblies were mapped
against P. aeruginosa reference genome POA1 to evaluate the core genome average identities
and completeness. The removal of probable contaminants was performed by BLAST against
the assembly sequences of mitochondrial and primates’/rodents chromosome databases. The
finalized draft genomes were submitted to Rapid Automated using Subsystem Technology
(RAST) [22] server for gene predictions and annotations. Prokka Version 1.11 (Prokaryotic
annotation) was used to perform the gene prediction [23]. The prediction is relied on the exist-
ing annotation resources such proteins and coding DNA sequences (CDS).
Analysis of single nucleotide polymorphism (SNP)
To identify genetic differences at genome level, the sequencing reads of each strain were
mapped to its corresponding reference genome P. aeruginosa POA1 using Bowtie v0.12.0 soft-
ware [24]. High-confidence SNP variants data sets were created by applying series of filters.
The Variants were identified and extracted using Samtools with the following parameters:
each variant must be supported by at least 10 reads (-d = 10), only the variants that were sup-
ported by maximum of 10,000 reads were considered for downstream analysis (-D = 10,000)
and the reads must be supported by mapping quality of equal or larger than 25 (MQ = 25).
Variants harbored by more than 90% of reads were included for further analysis and the depth
of coverage was 25x. The effects of nsSNPs were annotated using SnpEFF.
Genome comparison
Protein Basic Local Alignment Search Tool (BLASTp) was used to match the sequence similar-
ities between genomes of clinical isolates and the P. aeruginosa reference genome PAO1 [25].
Genome visualization of ten clinical isolates and the similarity between P. aeruginosa reference
genome (NC_002516.2) was performed using BLAST Ring Image Generator (BRIG) [26].
Heat map
Heat maps were generated using Complex Heat map package from Bioconductor in R [27].
Clusters are predicted using Euclidean distance method.
Results
Antibiotic-resistance profiles of P. aeruginosa clinical isolates
A total of ten P. aeruginosa clinical isolates with resistant to three or more of the nine antibiot-
ics tested were chosen for the study. The MIC values of nine antibiotics tested against the bac-
terial isolates are shown in Table 2. Isolates PAS2 and PAS10 were highly resistant to all the
antibiotics tested. In contrary, isolates PAS4 and PAS8 were susceptible to at least 3 antibiotics
(Imipenem, Meropenem and Collistin). PAS1 and PAS7 were only susceptible to Amikacin
and Piperacillin/Tazobactam respectively. All ten isolates were resistant to Ceftazidime,
Aztreonam, Gentamicin and Ciprofloxacin.
Genome sequencing and assembly
The sequencing consisted of 1 lane 100 bp paired-end reads, yielded approximately 0.8 Gbp to
2.8 Gbp for each clinical isolates. The draft genome assemblies for the ten Pseudomonas clini-
cal isolates have been submitted to NCBI bioproject under the project accession number
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PRJNA388357 (http://www.ncbi.nlm.nih.gov/bioproject/388357). More than 80% of the reads
are above Phred quality score of 30 indicating high quality sequencing data. The sequenced
data were subjected to contamination screening and the genome sizes of final assemblies were
ranging from 6.6 Mbp to 7.0 Mbp. The de novo assembly of genome sequence data revealed
that the number of contigs (>200 bp) varied from 185 to 492 for each genome. These contigs
were aligned to the reference genome of P. aeruginosa PAO1, and manual genome finishing
was performed. The maximum contig size among the genomes was 485,560 bp aligned to
PAS4. Genomes with the mean identity ranged from 98.77 for PAS 7 to 98.83 for PAS 9. The
GC content ranged from 65.79 for PAS 1 to 66.19 for PAS 2. A summary of the genome
sequence data and assembly are shown in Table 3.
Genome architecture
Fig 1 contains the circular map of the ten newly sequenced clinical isolates compared to the
reference genome PAO1. The inner most circle represents the reference genome of P. aerugi-
nosa (NC_002516.2) and outer most circle with labels represent the protein-coding regions
(CDS) with annotation on the genome. The shared identity of each isolate with the reference
genome is represented in different colors, which denotes the BLASTn matches between 70% to
100% nucleotide identities. The blank spaces in the rings represent the matches less than 70%
or no BLAST matches to the reference genome. The nsSNPs harbored on the genes compared
to the reference genome are represented as individual gene names.
Genome polymorphism
We focused our analysis on identifying nsSNPs that results in amino acid changes within the
functional gene sequences. In addition, we also screened for point mutations that leads to pre-
mature termination of codons or nucleotide deletions that create frame-shift mutations. We
initially screened the nsSNPs in clinical isolates compared to the P. aeruginosa reference
genome, PAO1. Fig 1 shows the genome organization of all the clinical isolates. The CDS
regions (in dark) and the genes harboring these regions containing nsSNPs were illustrated in
Fig 1. As high as 18,876 nsSNPs were identified in Amikacin resistant isolates when compared
to the PAO1 genome; whereas, only 81 nsSNPs were identified in Piperacillin resistant isolates
Table 2. Minimum inhibitory concentration (MIC) of the ten P. aeruginosa clinical isolates used in the current study.
Isolate IMP
(32)
MPM
(32)
CAZ
(48)
AZT
(16)
PPT
(24)
GN
(32)
AK
(24)
CIP
(4)
CL
(3)
PAS1 32 32 256 32 24 32 16 32 4
PAS2 32 32 256 32 32 48 24 32 6
PAS3 2 32 256 256 256 384 24 32 2
PAS4 2 3 256 256 256 1024 48 32 2
PAS5 1.5 32 256 24 128 1024 192 4 2
PAS6 1.5 3 256 64 256 1024 32 32 3
PAS7 32 32 256 24 16 48 32 32 3
PAS8 1.5 1 256 16 256 1024 98 12 1.5
PAS9 3 1.5 256 16 128 1024 128 16 6
PAS10 32 32 48 16 256 1024 256 32 4
Abbreviations: IMP, imipenem; MPM, meropenem; CAZ, ceftazidime; AZT, aztreonam; PPT, piperacillin/tazobactam; GN, gentamicin; AK, amikacin; CIP,
ciprofloxacin; CL, colistin.
The bracketed values indicate the breakpoints for the classification of resistance for the respective antibiotics.
https://doi.org/10.1371/journal.pone.0182524.t002
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(Fig 2). Majority of the nsSNPs were present within the PA2018, PA2019 and PA5471 loci that
code for aminoglycoside resistant genes mexAB-oprM and mexXY-oprM responsible for the
regulation of multi-drug efflux pump (Table 4).
Then we compared the resistant clinical isolates with the susceptible strains to extract spe-
cific nsSNPs found only in resistant isolates. The antibiotic profiles of Ceftazidime, Aztreo-
nam, Gentamicin and Ciprofloxacin were not included as all 10 isolates were resistant to these
antibiotics. The isolates classified as resistant for 5 different antibiotics were screened further
to identify the nsSNPs. For example, PAS 1 was susceptible to Amikacin and 9 isolates (PAS
2–10) were resistant to the antibiotic. Hence we compared the nsSNPs present within resistant
isolates. As shown in S1 Table, the amikacin resistant isolates possess two unique single nucle-
otide deletions that results in a frameshift mutation that truncates the protein products. Dele-
tion at nucleotide position 1275766 results in a frameshift mutation and truncation of protein
NapA (periplasmic nitrate reductase protein). Similarly, deletion at nucleotide position
1402975 results in truncation of 3-mercaptopyruvate sulfurtransferase. The detailed list of
unique nsSNPs identified in the resistant clinical isolates compared to susceptible isolates for 5
different antibiotics is shown in the S1 Table. S2 Table, S3 Table, S4 Table and S5 Table. Differ-
ential mutation screening between the isolates were performed to identify specific nsSNPs
associated with the particular antibiotic resistances.
In order to investigate nsSNPs in genes annotated to be associated in antibiotic resistance
[8] or virulence factors [28], we specifically extracted the nsSNPs presented in various anti-
biotic resistant genes of resistant and susceptible clinical isolates. The number of nsSNPs
shared within a gene across all clinical isolates is shown in Fig 3. For example, 6 nsSNPs
were found within the colistin resistant isolate (PAS1 and 2) when compared to colistin sus-
ceptible isolates (PAS 3 and 8) at the gene PA3292 that codes for a hypothetical protein.
Similarly, 6 nsSNPs were also seen in all the isolates except PAS 8 at the PA1923 gene that
Table 3. Illumina sequencing results for P. aeruginosa isolates.
Strain Number of
contig
Genome
Size (bp)
Reads per
pair
Minimum
Contig Size
(bp)
Maximum
Contig Size
(bp)
N50 Size
(bp)
% of
Q30
bases
GC
Content
(%)
Completeness
(%)
Average
Identity (%)
PAS1 325 6,909,968 28282644 200 404,308 102,152 84.02 65.79 80.34 98.82
PAS2 243 6,627,283 25135336 200 379,250 119,180 84.25 66.19 79.06 98.79
PAS3 322 6,731,789 20991654 200 327,510 102,161 91.29 66.12 79.68 98.80
PAS4
185
6,753,415 8898394 205 485,560 118,034 85.17 66.03 79.80 98.80
PAS5 230 6,954,778 9978228 200 404,098 105,908 84.81 65.93 81.22 98.81
PAS6 189 7,036,089 7154400 200 377,351 113,718 84.42 65.99 81.21 98.82
PAS7 492 6,851,779 10743970 200 319,361 91,918 84.64 65.90 80.25 98.77
PAS8 293 6,762,669 8407562 205 238,159 90,287 84.73 66.00 79.61 98.81
PAS9 279 7,050,477 8326856 200 363,660 102,446 83.79 65.85 81.65 98.83
PAS10 239 6,956,100 27086434 200 377,138 93,007 83.63 65.93 81.21 98.82
https://doi.org/10.1371/journal.pone.0182524.t003
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codes for cobaltochelatase subunit CobN. Many of the polymorphic genes among these
clinical isolates were mainly associated with cell wall, multi-drug efflux pump, protein
Fig 1. Genome map of clinical isolates compared to P. aeruginosa reference genome (NC_002516.2). All ten isolates were separated in rings. The
inner most circle represents the reference genome and outer most circle with labels represent the CDS (in dark). The percentage similarity between each
genome are represented in different colors. Map and underlying analysis were performed with the BLAST Ring Image Generator (BRIG) (http://sourceforge.
net/projects/brig).
https://doi.org/10.1371/journal.pone.0182524.g001
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secretion, DNA replication and genes involved in repair mechanism. In addition, nsSNPs
were found within genes responsible for resistance to β–lactams; transporter (PA4218),
transcriptional regulators (PA1184, PA0032, PA5293 and PA2383) and a hypothetical pro-
tein (PA3693). These were all collectively reported to play a role in decreased antibiotic
uptake and affecting cell wall permeability [29]. Notably, a SNP at position 2213177 in all
antibiotic resistant isolates changed tryptophan into a stop codon. Furthermore, two frame
shift mutations at the napA and PA1292 genes of Amikacin resistant genes and a mutation
resulting in stop codon at amino acid position Q65 in the Meropenem resistant isolates
might have implications in the drug resistant mechanism. These findings indicate that the
nsSNPs identified in the clinical isolates may contribute towards antibiotic resistance
between the resistant clinical isolates examined in the study. Further targeted evidence
using a large cohort of clinical isolates and site directed mutational analysis of these antibi-
otic resistant genes will provide further insights in the antibiotic resistant mechanism of the
P. aeruginosa.
Fig 2. Venn diagram showing the non-synonymous single nucleotide polymorphism (nsSNP’s) in
antibiotic resistant and susceptible clinical isolates aligned to the reference genome PAO1. The
unique nsSNP’s identified in (a) Amikacin, (b) Imipenem, (c) Colistin, (d) Meropenem and (e) Peperacillin/
Tazobactam resistant and susceptible isolates were depicted in the figure. The profiles of antibiotics
Ceftazidime, Aztreonam, Gentamicin and Ciprofloxacin were not included in the comparison since all ten
clinical isolates were resistant to these antibiotics.
https://doi.org/10.1371/journal.pone.0182524.g002
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Discussion
Whole genome sequencing promises high resolution, high-throughput genome sequencing
with insights to the repertoire of genetic polymorphism[3, 11]. This approach can be used to
identify the single nucleotide polymorphism that either alters a single amino acid or leads to a
stop codon, and frame-shift mutations that alters a gene sequence itself resulting in truncated
proteins. Here, we have investigated the genetic variation in P. aeruginosa hospital isolates by
high-throughput NGS technology and comparative genomics.
The clinical isolates included in this study were selected based on their multidrug resistant
profiles against a total of nine antibiotics. To study the genomic variation among the isolates
with varying antibiotic resistance characteristics, we analyzed the genomic sequences of the
isolates using WGS technique and compared the data with P. aeruginosa reference genome
PAO1.
Table 4. Key nsSNPs identified in the antibiotic resistant genes of P. aeruginosa multi-drug resistant isolates compared to PA01 reference
genome.
SNP in
isolate
SNP in
PAO1
Position in
PAO1
PAO1
locus
PAO1 amino
acid
SNP amino
acid
Amino acid
position
Protein
G T 2208200 PA2018 N T 1036 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
C G 2208789 PA2018 Q E 840 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
T C 2209400 PA2018 S N 636 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
G C 2209541 PA2018 G A 589 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
C T 2209680 PA2018 T A 543 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
C T 2209701 PA2018 I V 536 Resistance–Nodulation-Cell division (RND)
multidrug efflux transporter
G A 2211441 PA2019 W R 358 Resistance–Nodulation-Cell division (RND)
multidrug efflux membrane fusion protein
C A 2211522 PA2019 L V 331 Resistance–Nodulation-Cell division (RND)
multidrug efflux membrane fusion protein
G T 2211528 PA2019 K Q 329 Resistance–Nodulation-Cell division (RND)
multidrug efflux membrane fusion protein
C T 6159991 PA5471 I V 237 ArmZ
T C 6160365 PA5471 S N 112 ArmZ
G A 6160582 PA5471 C R 40 ArmZ
A G 4722060 PA4218 L F 267 AmpP
C T 34646 PA0032 L P 8 Probable Transcriptional regulator
T C 1286548 PA1184 A T 81 Probable Transcriptional regulator
T G 5959101 PA5293 D E 75 Probable Transcriptional regulator
A C 4135835 PA3693 A S 47 Macro domain-containing protein
G A 2635770 PA2383 S P 68 Probable Transcriptional regulator
G A 6159972 PA5471 V A 243 ArmZ
G A 2211441 PA2019 W R 358 Resistance–Nodulation-Cell division (RND)
multidrug efflux membrane fusion protein
A G 2213177 PA2020 W * 167 MexZ
C T 5959144 PA5293 Q R 61 Probable Transcriptional regulator
* Indicates mutation that leads to a stop codon
https://doi.org/10.1371/journal.pone.0182524.t004
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Fig 3. Heat-map representing the number of non-synonymous SNPs found within different antibiotic-
resistant clinical isolates of P. aeruginosa. The number of SNP’s identified in each clinical isolate with
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Several non-synonymous SNPs that may play an important role in antibiotic resistance
have been identified, with insights to enhance our current understanding of the factors that
influence the antibiotic resistance regime of hospital isolates. Though we have studied the
nsSNPs of entire genome of all hospital isolates, we specifically extracted nsSNPs that were in
genes reported to play a major implication in antibiotic resistance [28] within the antibiotic
resistant and susceptible clinical isolates. Several mechanisms of antibiotic resistance in P. aer-
uginosa have been reported: by altering porins or outer membrane properties, resistance
through enzymatic modification of drugs, and resistance through efflux systems and chromo-
somal mutations within regulatory genes [30–33].
We have identified specific nsSNPs within the mexXY-oprM and mexAB-oprM genes,
which are known to play a major role in antibiotic resistance through efflux pumps and both
these genes part the same efflux porin OprM [34, 35]. In addition, the efflux system Mex-
XY-OprM is also recognized to be contributing in aminoglycoside resistance in P. aeruginosa,
and MexAB-OprM is reported to confer resistance to β—lactams, aminoglycosides and fluoro-
quinolones resistance [31, 36]. Also a polymorphism resulting in a stop codon at locus PA2020
corresponding to a mexZ transcriptional regulator may have implications in drug resistance
[37]. Collectively, P. aeruginosa may use a combination of all these mechanisms to achieve
multi-drug antibiotic resistance.
The unique nsSNPs identified within the genes coding for aminoglycoside modifying
enzymes (AME’s) and 16S rRNA methylase genes, mutations leading to colistin resistance by
altering the bacterial outer membrane, and resistant to β lactam by hyper production of β-lac-
tamase AmpC may together play a crucial role in multi-drug resistance. Our results confirm
the assumption of other authors that the drug resistance may be the result of a pool of pathoge-
nicity-related genes that interact in various combinations [29, 38, 39]. In addition to the
unique mutations, there is high degree of sequence conservation between resistant and suscep-
tible clinical isolates. This conservation within the virulence genes of different P. aeruginosa
clinical isolates may be a factor that is challenging to device strategies for the treatment of
infections. In addition, the extensive conservation of virulence genes in the genomes regardless
of drug resistance may be due to the fact that the disease-causing ability of this opportunistic
pathogen relies on a set of highly conserved pathogenic mechanisms [29]. Moreover, the resis-
tance of one isolate for several antibiotics may be due to the pleiotropic effects of resistance
causing gene [39].
Drug resistance to several antibiotics may be due to a combination of mutations resulting
in overexpression of several multi-drug efflux pumps, alteration of expression of enzymes and
structural components involved in peptidoglycan outer membrane stability, mutations affect-
ing gyrase activity and mutations taking effect in aminoglycoside phosphotransferases [29]. In
our study, the analysis of the genomes of drug resistant clinical isolates possessed non-synony-
mous mutations in at least one gene known to be involved in antibiotic resistance (for exam-
ple, oprD, gyrA or B, mex-type efflux systems, parC, rpoB, baeS). The genes carrying these
mutations are coding for proteins involved in outer membrane permeability, multi- drug
efflux pumps, gyrases and drug modifying enzymes (aminoglycoside modification enzymes
and/ or β -lactamases) [39]. However, a limitation of this study is that further targeted evidence
with site directed mutational analysis on the reported nsSNPs harboring the resistant genes is
respect to their antibiotic resistant profile is depicted in the heat-map. The red colour indicates there are 6
nsSNPs harbouring in that gene among different isolates and a blue colour represents there are no nsSNPs
within the gene among isolates.
https://doi.org/10.1371/journal.pone.0182524.g003
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required. Such analysis will provide further insights to the overall phenotype alteration and
synergistic effect of these nsSNPs in the antibiotic resistant mechanism.
In conclusion, this study demonstrates the potential of next generation high-throughput
whole genome sequencing to compare the genome polymorphism between clinical isolates.
We have identified a number of key mutations that may play a key role in altering antibiotic
resistant genes leading to genetic polymorphism. This should form the basis of our future
research to study the prevalence of such multidrug resistance P. aeruginosa in the Asia pacific
region. This technology can be utilised in conjunction with current epidemiological studies,
diagnostic assays and antimicrobial susceptibility tests to reveal the genetic variation and path-
ogen biology of “high-risk” pathogens including P. aeruginosa [11].
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